Cite
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.
MLA
Moros, Alexandra, et al. “Immunogenicity and Safety in Pigs of PHH-1V, a SARS-CoV-2 RBD Fusion Heterodimer Vaccine Candidate.” Vaccine, vol. 41, no. 35, Aug. 2023, pp. 5072–78. EBSCOhost, https://doi.org/10.1016/j.vaccine.2023.07.008.
APA
Moros, A., Prenafeta, A., Barreiro, A., Perozo, E., Fernández, A., Cañete, M., González, L., Garriga, C., Pradenas, E., Marfil, S., Blanco, J., Cebollada Rica, P., Sisteré-Oró, M., Meyerhans, A., Prat Cabañas, T., March, R., & Ferrer, L. (2023). Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate. Vaccine, 41(35), 5072–5078. https://doi.org/10.1016/j.vaccine.2023.07.008
Chicago
Moros, Alexandra, Antoni Prenafeta, Antonio Barreiro, Eva Perozo, Alex Fernández, Manuel Cañete, Luis González, et al. 2023. “Immunogenicity and Safety in Pigs of PHH-1V, a SARS-CoV-2 RBD Fusion Heterodimer Vaccine Candidate.” Vaccine 41 (35): 5072–78. doi:10.1016/j.vaccine.2023.07.008.